| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $529.8M | $91.5M | $9.8M |
| YoY Revenue Growth % | +479.0% | +833.7% | — |
| Gross Profit | $363.6M | $47.8M | — |
| Gross Margin % | 68.6% | 52.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$611.7M | -$399.6M | -$285.7M |
| Operating Margin % | -115.5% | -436.7% | -2915.3% |
| Net Income (GAAP) | $82.5M | -$641.4M | $241.3M |
| EBITDA (Normalized) | $2.64B | $246.4M | -$285.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $384.8M | $245.6M | $829.8M |
| Capital Expenditures (CapEx) | $4.07B | $807.5M | $441.0K |
| Free Cash Flow (FCF) | -$3.68B | -$561.9M | $829.4M |
| FCF Margin % | -694.8% | -614.1% | 8462.8% |
| Return on Invested Capital (ROIC %) | -9.6% | -33.2% | -1.5% |
| Cash & Short-Term Equivalents | $3.68B | $2.43B | — |
| Total Debt (Short + Long Term) | $4.10B | $132.7M | $6.02B |
| Total Stockholders' Equity | $4.59B | $3.25B | $12.34B |